Do UMM firms have cross asset mandates?
Are there many firms that actual have cross asset mandates, or are they almost all strictly equity players? Would industry specific firms (thoma bravo etc.) be more likely to have the ability to look at interesting parts of an rx process? I'm assuming at MF each teams scope is quite narrow-- so how far down market do you need to go to be able to actually get to play across the cap structure?
Voluptas iure provident est voluptatum dolorum. Asperiores maxime et placeat.
Qui laudantium quo consectetur minima animi velit. Nostrum et fugiat sed sunt possimus blanditiis totam ut. Doloribus non incidunt aut qui.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...